Abstract
Purpose
To investigate the relationships between bone measures, vitamin D status and markers of glucose metabolism among diabetic and non-diabetic adults.
Methods
Cross sectional study with 298 adults (mean age 57.5 years, SD = 14.8; 44.3% male, 16.9% diabetic) participants of the Health Survey–São Paulo (ISA-Capital) 2014–2015. Blood samples were collected to assess serum glucose, insulin and 25 hydroxyvitamin D [25(OH)D] concentrations. Dual-energy x-ray absorptiometry (DXA) was performed to determine total body fat; total lean mass; full body bone mineral density (BMD); lumbar spine BMD and bone mineral content (BMC); and femur BMD and BMC. Fat mass index (FMI), lean mass index (LMI), quantitative insulin sensitivity check index (QUICKI), homeostasis model assessment of insulin resistance (HOMA-IR) and of β-pancreatic cell function (HOMA-β) were calculated. Linear regression analysis were performed.
Results
Multiple bone measures were associated with markers of glucose metabolism in analyses adjusted by age and sex. However, after additional adjustments by LMI, FMI and serum 25(OH)D, only associations of lumbar spine BMC with HOMA-IR (β = 0.167; p = 0.035) and QUICKI (β = -1.879; p = 0.027) persisted, in the subgroup of diabetic participants. Analysis restricted to diabetic subjects revealed stronger correlations between bone parameters and markers of glucose metabolism.
Conclusions
Our study observed positive associations between BMD and markers of insulin resistance among a sample of adults. Correlations were stronger among diabetic subjects, and some associations between bone and glucose metabolism were independent of adiposity. Findings reinforce the need of further research for better understanding the bidirectional and multifactorial crosstalk between glucose homeostasis and bone metabolism.
Similar content being viewed by others
Data availability
Data will be made available on request.
Code availability
Not applicable.
References
Lee NK, Sowa H, Hinoi E, Ferron M, Ahn JD, Confavreux C, et al. Endocrine regulation of energy metabolism by the skeleton. Cell. 2007;130(3):456–69.
Wolf G. Function of the bone protein osteocalcin: definitive evidence. Nutr Rev. 1996;54(10):332–3.
Wood RJ. Vitamin D and adipogenesis: new molecular insights. Nutr Rev. 2008;66(1):40–6.
Díez JJ, Iglesias P. The role of the novel adipocyte-derived hormone adiponectin in human disease. Eur J Endocrinol. 2003;148(3):293–300.
Ducy P, Amling M, Takeda S, Priemel M, Schilling AF, Beil FT, et al. Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell. 2000;100(2):197–207.
Stefan N, Vozarova B, Funahashi T, Matsuzawa Y, Weyer C, Lindsay RS, et al. Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans. Diabetes. 2002;51(6):1884–8.
Ferron M, Hinoi E, Karsenty G, Ducy P. Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. Proc Natl Acad Sci U S A. 2008;105(13):5266–70.
Kaneko I, Sabir MS, Dussik CM, Whitfield GK, Karrys A, Hsieh J-C, et al. 1,25-Dihydroxyvitamin D regulates expression of the tryptophan hydroxylase 2 and leptin genes: implication for behavioral influences of vitamin D. FASEB J. 2015;29(9):4023–35.
Maestro B, Molero S, Bajo S, Dávila N, Calle C. Transcriptional activation of the human insulin receptor gene by 1,25-dihydroxyvitamin D(3). Cell Biochem Funct. 2002;20(3):227–32.
Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357(3):266–81.
Pannu PK, Calton EK, Soares MJ. Calcium and vitamin D in obesity and related chronic disease. Adv Food Nutr Res. 2016;77:57–100.
Starup-Linde J, Hygum K, Langdahl BL. Skeletal fragility in type 2 diabetes mellitus. Endocrinol Metab (Seoul). 2018;33(3):339–51.
Poiana C, Capatina C. Fracture risk assessment in patients with diabetes mellitus. J Clin Densitom. 2017;20(3):432–43.
Fulzele K, Riddle RC, DiGirolamo DJ, Cao X, Wan C, Chen D, et al. Insulin receptor signaling in osteoblasts regulates postnatal bone acquisition and body composition. Cell. 2010;142(2):309–19.
Kanazawa I, Sugimoto T. Diabetes mellitus-induced bone fragility. Intern Med. 2018;57(19):2773–85.
World Health Organization. Physical Status: the use and interpretation of anthropometry: Report of a WHO expert committee. (WHO technical report series; 854). Geneva; 1995.
Organización Panamericana de la Salud. División de Promoción y Protección de la Salud (HPP). Encuesta multicentrica salud bienestar y envejecimiento (SABE) en América Latina: informe preliminar. Multicenter survey aging, health and wellbeing in Latin América and the Caribbean (SABE): preliminary report. Reunión del Comité Asesor de Investigaciónes en Salud. Washington D.C.; 2001.
Kelly TL, Wilson KE, Heymsfield SB. Dual energy X-Ray absorptiometry body composition reference values from NHANES. PloS One. 2009;4(9):e7038.
Kanis JA, McCloskey EV, Johansson H, Oden A, Melton LJ, Khaltaev N. A reference standard for the description of osteoporosis. Bone. 2008;42(3):467–75.
Schousboe JT, Shepherd JA, Bilezikian JP, Baim S. Executive summary of the 2013 ISCD position development conference on bone densitometry. JCD 2013;16(4):455–7.
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412–9.
Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab. 2000;85(7):2402–10.
Sempos CT, Heijboer AC, Bikle DD, Bollerslev J, Bouillon R, Brannon PM, DeLuca HF, Jones G, Munns CF, Bilezikian JP, Giustina A, Binkley N. Vitamin D assays and the definition of hypovitaminosis D: results from the first international conference on controversies in vitamin D: vitamin D assays and defining hypovitaminosis D. Br J Clin Pharmacol. 2018;84(10):2194–207. https://doi.org/10.1111/bcp.13652.
Vestergaard P. Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes–a meta-analysis. Osteoporos Int. 2007;18(4):427–44.
Strotmeyer ES, Cauley JA, Schwartz AV, Nevitt MC, Resnick HE, Zmuda JM, et al. Diabetes is associated independently of body composition with BMD and bone volume in older white and black men and women: the Health, Aging, and Body Composition Study. J Bone Miner Res. 2004;19(7):1084–91.
Ma L, Oei L, Jiang L, Estrada K, Chen H, Wang Z, et al. Association between bone mineral density and type 2 diabetes mellitus: a meta-analysis of observational studies. Eur J Epidemiol. 2012;27(5):319–32.
Dennison EM, Syddall HE, Aihie Sayer A, Craighead S, Phillips DIW, Cooper C. Type 2 diabetes mellitus is associated with increased axial bone density in men and women from the Hertfordshire Cohort Study: evidence for an indirect effect of insulin resistance? Diabetologia. 2004;47(11):1963–8.
Haffner SM, Bauer RL. The association of obesity and glucose and insulin concentrations with bone density in premenopausal and postmenopausal women. Metabolism. 1993;42(6):735–8.
Schwartz AV, Vittinghoff E, Bauer DC, Hillier TA, Strotmeyer ES, Ensrud KE, et al. Association of BMD and FRAX score with risk of fracture in older adults with type 2 diabetes. JAMA. 2011;305(21):2184–92.
Wongdee K, Charoenphandhu N. Update on type 2 diabetes-related osteoporosis. World J Diabetes. 2015;6(5):673–8.
Ho-Pham LT, Chau PMN, Do AT, Nguyen HC, Nguyen TV. Type 2 diabetes is associated with higher trabecular bone density but lower cortical bone density: the Vietnam Osteoporosis Study. Int. 2018;29(9):2059–67.
Gan W, Clarke RJ, Mahajan A, Kulohoma B, Kitajima H, Robertson NR, et al. Bone mineral density and risk of type 2 diabetes and coronary heart disease: a Mendelian randomization study. Wellcome Open Res. 2017;2:68.
Hardy OT, Czech MP, Corvera S. What causes the insulin resistance underlying obesity? Curr Opin Endocrinol Diabetes Obes. 2012;19(2):81–7.
Ye J. Mechanisms of insulin resistance in obesity. Front Med. 2013;7(1):14–24.
Shapses SA, Pop LC, Wang Y. Obesity is a concern for bone health with aging. Nutr Res N Y N. 2017;39:1–13.
Park K-Y, Hwang H-S, Park H-K. Modifiable lifestyle factors associated with osteoporosis in Korean men: a case-control study. Arch Osteoporos. 2017;12(1):56.
da Silva AP, Matos A, Ribeiro R, Gil Â, Valente A, Bicho M, et al. Sarcopenia and osteoporosis in Portuguese centenarians. Eur J Clin Nutr. 2017;71(1):56–63.
Sutton ALM, MacDonald PN. Vitamin D: more than a “bone-a-fide” hormone. Mol Endocrinol Baltim Md. 2003;17(5):777–91.
Neve A, Corrado A, Cantatore FP. Osteocalcin: skeletal and extra-skeletal effects. J Cell Physiol. 2013;228(6):1149–53.
Meehan M, Penckofer S. The role of vitamin D in the aging adult. J Aging Gerontol. 2014;2(2):60–71.
Barrett-Connor E, Kritz-Silverstein D. Does hyperinsulinemia preserve bone? Diabetes Care. 1996;19(12):1388–92.
Barroso LN, Farias DR, Soares-Mota M, Bettiol H, Barbieri MA, Foss MC, Silva AAMD, Kac G. Waist circumference is an effect modifier of the association between bone mineral density and glucose metabolism. Arch Endocrinol Metab. 2018;62(3):285–95.
Funding
This study was supported by the Brazilian National Council for Scientific and Technological Development (Conselho Nacional de Desenvolvimento Científico e Tecnológico – CNPq) 150754/2017-5 (KVG’s postdoctoral scholarship) and by São Paulo Research Foundation (Fundação de Amparo à Pesquisa do Estado de São Paulo – FAPESP) 15/07971-7 (project funding), 14/26787-0 (NAGF’s PhD scholarship). CNPq and FAPESP had no role in the design, analysis or writing of this article.
Author information
Authors and Affiliations
Contributions
Kelly Virecoulon Giudici: Conceptualization, Methodology, Formal Analysis, Writing- Original draft preparation. Natasha Aparecida Grande de França: Investigation, Data curation, Writing – Review & Editing. Barbara Santarosa Emo Peters: Investigation, Data curation, Writing – Review & Editing. Regina Mara Fisberg: Project Administration, Supervision, Writing- Reviewing and Editing. Lígia Araújo Martini: Conceptualization, Methodology, Supervision, Funding Acquisition, Writing- Reviewing and Editing.
Corresponding author
Ethics declarations
Ethics approval
The study was approved by the Ethics in Research Committee from the School of Public Health of the University of São Paulo (FSP/USP) (ISA-Capital 2014–2015 general protocol number: 32344014.3.0000.5421; blood collection: 36607614.5.0000.5421; DXA: 44552815.0.0000.5421).
Consent to participate
All participants were informed about the objectives of research and signed an informed consent form.
Consent for publication
Not applicable.
Conflict of interest
On behalf of all authors, the corresponding author states that there is no conflict of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Giudici, K.V., de França, N.A.G., Peters, B.S.E. et al. Associations between markers of glucose metabolism and bone measures among diabetic and non-diabetic adults. J Diabetes Metab Disord 20, 1247–1255 (2021). https://doi.org/10.1007/s40200-021-00849-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40200-021-00849-5